Literature DB >> 23105622

The influence of tobacco smoking on humoral immune response in insulin dependent diabetic pregnancy.

Medhat Haroun1.   

Abstract

Tobacco smoking products have a heavy impact on the public health of developed as well as non-developed countries by being a main etiologic factor for the induction of cardiovascular diseases and tobacco-related cancer. The purpose of this study was to determine the influence of tobacco smoking on the measurement of the humoral immune response in Egyptian pregnant women with type 1 diabetes. Concentrations of serum immunoglobulin A, G and M in 35 smoking, 35 non-smoking pregnant women with type 1 diabetes and 35 matched normal women were measured by ELISA. Women were matched by age and working life with controls. Measurements suggested that diabetic smokers had decreased levels of IgG and IgM in their sera. It was found that normal individuals had mean IgA, IgG and IgM levels of 2.80 mg/ml, 9.33 mg/ml and 1.66 mg/ml, respectively while non-smoker women suffering from type 1 diabetes had mean levels of 3.47 mg/ml, 10.97 mg/ml and 2.05 mg/ml (p<0.0004,p<0.0001 andp<0.0002). However, the mean level of IgA, IgG and IgM in diabetic smoker sera was determined to be 3.33 mg/ml, 8.07 mg/ml and 1.31 mg/ml, respectively (p<0.003,p<0.0001 andp<0.0001). The obtained results suggest that toxic smoke components were immuno-suppressant and may well play a part in the complex immuno-pathogenesis interaction. The increased risk of smoking in insulin dependent diabetic pregnant women during pregnancy is a further reason to encourage pregnant women to quit tobacco smoking.

Entities:  

Keywords:  Immunoglobulins; Pregnancy; Smoking; Type 1 diabetes

Year:  2006        PMID: 23105622      PMCID: PMC3453972          DOI: 10.1007/BF02912920

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  32 in total

1.  The effects of maternal cigarette smoking on placental morphology, histomorphometry, and biochemistry.

Authors:  D Rush; A Kristal; W Blanc; C Navarro; P Chauhan; M Campbell Brown; P Rosso; M Winick; J Brasel; R Naeye
Journal:  Am J Perinatol       Date:  1986-07       Impact factor: 1.862

Review 2.  Quantitative enzyme immunoassay (ELISA) in microbiology.

Authors:  E Engvall
Journal:  Med Biol       Date:  1977-08

Review 3.  Epidemiology of chronic obstructive pulmonary disease.

Authors:  D L Sherrill; M D Lebowitz; B Burrows
Journal:  Clin Chest Med       Date:  1990-09       Impact factor: 2.878

4.  The associations of race, cigarette smoking, and smoking cessation to measures of the immune system in middle-aged men.

Authors:  F Mili; W D Flanders; J R Boring; J L Annest; F Destefano
Journal:  Clin Immunol Immunopathol       Date:  1991-05

5.  Maternal cigarette smoking during pregnancy increases the risk of having a child with a congenital digital anomaly.

Authors:  Li-Xing Man; Benjamin Chang
Journal:  Plast Reconstr Surg       Date:  2006-01       Impact factor: 4.730

6.  Consequences of smoking and caffeine consumption during pregnancy in women with type 1 diabetes.

Authors:  J C Khoury; M Miodovnik; C R Buncher; H Kalkwarf; S McElvy; P R Khoury; B Sibai
Journal:  J Matern Fetal Neonatal Med       Date:  2004-01

7.  Type 1 diabetes mellitus in childhood: a matched case control study in Lancashire and Cumbria, UK.

Authors:  A L Marshall; A Chetwynd; J A Morris; M Placzek; C Smith; A Olabi; D Thistlethwaite
Journal:  Diabet Med       Date:  2004-09       Impact factor: 4.359

8.  Smoking during pregnancy and congenital limb deficiency.

Authors:  A E Czeizel; I Kodaj; W Lenz
Journal:  BMJ       Date:  1994-06-04

9.  Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands.

Authors:  Inge M Evers; Harold W de Valk; Gerard H A Visser
Journal:  BMJ       Date:  2004-04-05

Review 10.  Ambient air pollution and pregnancy outcomes: a review of the literature.

Authors:  Radim J Srám; Blanka Binková; Jan Dejmek; Martin Bobak
Journal:  Environ Health Perspect       Date:  2005-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.